We are live on
!
Find out more
BG
Bahl & Gaynor Portfolio holdings
AUM
$19.8B
1-Year Est. Return
19.53%
This Fund
S&P 500
This Quarter
Est. Return
+0.89%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$5.29B
AUM Growth
–
Cap. Flow
+$5.37B
Cap. Flow
% of AUM
101.51%
Top 10 Holdings %
Top 10 Hldgs %
28.42%
Holding
359
New
359
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$330M |
| 2 |
Johnson & Johnson
JNJ
|
+$164M |
| 3 |
McDonald's
MCD
|
+$164M |
| 4 |
Chevron
CVX
|
+$132M |
| 5 |
Intel
INTC
|
+$129M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 16.23% |
| 2 | Technology | 15.85% |
| 3 | Healthcare | 14.87% |
| 4 | Energy | 12.34% |
| 5 | Industrials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Interparfums
IPAR
$4B
| $499K | 0.01% |
+17,490
| New | +$509K |
|
|
CB
227
DELISTED
CHUBB CORPORATION
CB
| $497K | 0.01% |
+5,874
| New | +$514K |
|
228
Stratasys
SSYS
$706M
| $496K | 0.01% |
+5,920
| New | +$477K |
|
229
West Pharmaceutical
WST
$24.5B
| $474K | 0.01% |
+13,500
| New | +$444K |
|
|
FDO
230
DELISTED
FAMILY DOLLAR STORES
FDO
| $474K | 0.01% |
+7,610
| New | +$472K |
|
231
Rollins
ROL
$18.4B
| $471K | 0.01% |
+61,317
| New | +$441K |
|
|
HUB.A
232
DELISTED
HUBBELL INC CL-A
HUB.A
| $468K | 0.01% |
+5,200
| New | +$452K |
|
233
Texas Roadhouse
TXRH
$13.8B
| $465K | 0.01% |
+18,590
| New | +$425K |
|
234
General Dynamics
GD
$103B
| $464K | 0.01% |
+5,918
| New | +$440K |
|
235
iShares Core S&P Mid-Cap ETF
IJH
$124B
| $460K | 0.01% |
+19,915
| New | +$462K |
|
236
Ziff Davis
ZD
$1.99B
| $456K | 0.01% |
+12,328
| New | +$431K |
|
|
EEP
237
DELISTED
Enbridge Energy Partners
EEP
| $454K | 0.01% |
+14,900
| New | +$445K |
|
238
iShares MSCI Hong Kong ETF
EWH
$1.23B
| $453K | 0.01% |
+24,700
| New | +$488K |
|
239
J&J Snack Foods
JJSF
$1.48B
| $450K | 0.01% |
+5,790
| New | +$439K |
|
|
NVO
240
Novo Nordisk
NVO
$208B
| $448K | 0.01% |
+28,900
| New | +$481K |
|
241
Eastman Chemical
EMN
$8.23B
| $446K | 0.01% |
+6,374
| New | +$444K |
|
|
CMD
242
DELISTED
Cantel Medical Corporation
CMD
| $445K | 0.01% |
+19,725
| New | +$427K |
|
|
IBKC
243
DELISTED
IBERIABANK Corp
IBKC
| $445K | 0.01% |
+8,295
| New | +$414K |
|
244
Brown & Brown
BRO
$24B
| $443K | 0.01% |
+27,480
| New | +$435K |
|
245
Monro
MNRO
$399M
| $443K | 0.01% |
+9,222
| New | +$406K |
|
|
SYNT
246
DELISTED
Syntel Inc
SYNT
| $435K | 0.01% |
+13,830
| New | +$451K |
|
247
iShares Russell Mid-Cap ETF
IWR
$56.3B
| $432K | 0.01% |
+13,304
| New | +$431K |
|
248
Ross Stores
ROST
$81.1B
| $432K | 0.01% |
+13,340
| New | +$427K |
|
249
Costco
COST
$423B
| $427K | 0.01% |
+3,862
| New | +$422K |
|
|
K
250
DELISTED
Kellanova
K
| $424K | 0.01% |
+7,039
| New | +$424K |
|
Similar funds
NIM
HHII
SPIA
MIM
EIM
OSAM
P
Bahl & Gaynor's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Bahl & Gaynor, which disclosed 359 positions worth $5.29B. Its ten largest holdings account for 28% of the portfolio.
Its largest position is Procter & Gamble: 4,199,813 shares worth $323M.
By sector, the portfolio is most concentrated in Consumer Staples at 16% of assets, followed by Technology and Healthcare.
- Bahl & Gaynor's largest Q2 2013 buy was Procter & Gamble: 4,199,813 shares worth $323M.
- Bahl & Gaynor's ten largest holdings make up 28% of its $5.29B portfolio in Q2 2013.
- Bahl & Gaynor disclosed 359 positions in Q2 2013, its first 13F filing on record.
Based on Bahl & Gaynor's 13F filing for Q2 2013, filed 16 Aug 2013.